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Evidence Base for the Use of Selected Complementary and
Alternative Therapies by Patients With Diabetes
Preface

Ruth Lindquist, PhD, RN,
ACNS-BC, FAAN, and Byron
Hoogwerf, MD, FACP, CDE, FACE,
Guest Editors

Complementary and alternative medicine (CAM) and associated therapies
are getting increased attention as
growing numbers of Americans are
exploring their use. The term “complementary medicine” refers to therapies
that are used with or taken in conjunction with allopathic Western medicine.
The term “alternative therapies” refers
to therapies that are considered nontraditional, non-Western therapies
that are used instead of allopathic
medicine. The term “integrative medicine” is the more current designation
of such non-Western therapies and systems of care. The term is inclusive and
provides a more comprehensive consideration of a blending or integration
of therapies used in Western and nonWestern systems of care. However,
the term “CAM” is perhaps the
most familiar and is used more commonly throughout the articles in this
Diabetes Spectrum From Research to
Practice section.
CAM therapies are growing in
popularity among both the public and
health care professionals. In fact, it
has been reported that annual visits
to providers of CAM therapies now
outnumber visits to primary care physicians.1 The annual National Health
Survey in 2007 found that 38.8% of
adults and 11.8% of children in the
United States reported use of a form of
CAM in the previous 12 months.2,3
T he f requenc y of C A M use
demands increased familiarity with
the range of therapies by both patients
and providers to ensure that safety
is maintained, interactions among
therapies are anticipated to minimize
possible adverse effects, and the full
benefits of therapies of Western and
non-Western origin may be realized.
The CAM therapies selected for discussion in this research section are
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ones that have, in our view, particular
relevance to people with diabetes and
that have both the potential likelihood
of benefit and—equally important—
the possibility to do harm if misused.
Furthermore, we have selected therapies that have been demonstrated to be
of popular interest and that are likely
to be encountered in practice.
There is growing interest in lifestyle approaches to stress reduction
and in health practices such as physical activity; interest is also strong in
the areas of dietary supplements and
herbal remedies to enhance health
and well-being. The availability of
CAM therapies and services has been
associated with increased consumer
satisfaction. However, there is concern
about untoward effects of prescribed
drug therapy and herbal supplement
interaction; overuse of therapies; or
misuse and adverse side effects and
outcomes. A solid evidence base for
use of CAM would go far toward
answering the questions of consumers
and providers regarding safety, as well
as help to evaluate cost-effectiveness
for third-party payment or out-ofpocket costs.4
This research section begins with
an article focused on lifestyle counseling of patients with diabetes inclusive
of CAM (p. 203). In this article, author
Patti Geil, MS, RD, FADA, CDE,
emphasizes that all patients should
be queried about their use of CAM
therapies, including their use of overthe-counter preparations. However,
health care providers should consider
not only the safety of the concomitant
use of CAM therapies, but also the
potential benefits that CAM therapies
could offer to people with diabetes.
Geil offers practical advice for counseling and collaborating on patients’
wise use of CAM therapies.
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patients’ questions or to offer referrals
is vital.
Healthy lifestyles for people who
have the diagnosis of diabetes or who
have pre-diabetes is a topic of interest to growing numbers of Americans.
Our fourth article, by Ulf G. Bronas,
PhD, ATC, ATR, et al. (p. 220),
reviews the role of physical activity
in diabetes, with a special emphasis
on nontraditional movement therapies
such as tai chi, qigong, and yoga. The
authors examine the potential effects
of such forms of exercise on glycemic control for people with impaired
glucose tolerance and type 2 diabetes. These nontraditional therapies
are popular, and thus it is important
that evidence of their effects on and
applicability to diabetes are examined.
The authors conclude, attendant with
the obvious interest in these forms of
physical activity, that more research in
this area is clearly required.
Stress is commonplace in our
modern world. Meditation, especially
Mindfulness-Based Stress Reduction
(MSBR), 5 has become popular and
widely practiced; its potential for
use by people with diabetes is evaluated in our final article by Robin R.
Whitebird, PhD, MSW, et al. (p. 226).
Their review documents the rising public interest in meditation and related
strategies for stress management and
the need for carefully designed trials
to determine the effects of MSBR and
related interventions on such outcomes
as glycemic control, stress management, and quality of life in diabetic
patients. However, strong evidential
scientific support specific to the use
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of MBSR by people with diabetes is
woefully lacking; more research is also
needed in the area.
We hope that the content in this
issue will be valuable to readers who
seek to provide effective, up-to-date,
high-quality care to patients with
diabetes. We also hope that this issue
provides foundational evidence-based
information to underlie the counsel
and care of diabetic patients, especially
regarding the use of CAM therapies.
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The next articles, by Laura ShaneMcWhorter, PharmD, BCPS, FASCP,
BC-ADM, CDE (p. 206) and Joe
M. Chehade, MD, Mae Sheikh-Ali,
MD, and Arshag D. Mooradian,
MD (p. 214), focus on botanical/
biological therapies and selected
vitamins and minerals and herbal
extracts, respectively. These articles
provide outstanding updates on the
evidence—or often a lack of or only
limited evidence—underlying the use
of these therapies. Indeed, in many
cases, the evidence is sparse, with few
definitive trials supporting benefits of
use for these substances, particularly
for people with diabetes.
However, perhaps as important are
studies providing evidence—although
limited—of the safety of their use,
particularly when used in conjunction
with other medications by people with
diabetes. These two articles help readers understand the array of biological
agents commonly used by patients
and provide information that may be
relevant to their patients’ health and
safety. The authors emphasize the
importance of assessing the combined
use of these non-Western therapies
with traditional therapies to avoid
potential adverse effects. They also
review and discuss existing evidence
in the current literature regarding the
benefits of these therapies. In working with patients who have access to a
world of opportunity to take prescription and nonprescription substances,
it is important to educate and counsel
patients about the potential risks and
benefits of using a variety of biological substances. The ability to answer

